Healthcare – Page 17

Newswire

[ July 16, 2026 ] AST SpaceMobile (NASDAQ: ASTS) Stock Analysis: Building World’s First Space-Based Broadband Provider Arena Signals
[ July 14, 2026 ] GameStop (NYSE: GME) Stock Analysis: Profitable Turnaround — Is Ryan Cohen This Generation’s Warren Buffett? Arena Signals
[ July 14, 2026 ] Quantum (NASDAQ: QMCO) Stock Analysis: Rebuilding the Data Infrastructure Company for the AI Era Arena Signals
[ July 14, 2026 ] Expensify (NASDAQ: EXFY) Stock Analysis: Building the AI-Native Financial Superapp for Business Spending Arena Signals
[ July 14, 2026 ] 3D Systems (NYSE: DDD) Stock Analysis: “Med tech, dental, and aerospace and defense, are rapidly adopting 3D printing as a core manufacturing method.” Arena Signals
[ July 14, 2026 ] PagerDuty (NYSE: PD) Stock Analysis: Becoming the AI Control Plane for Enterprise Operations Arena Signals
[ July 14, 2026 ] Xometry (NASDAQ: XMTR) Stock Analysis: Building the AI-Native Operating System for Global Manufacturing Arena Signals
[ July 10, 2026 ] Wrap Technologies (NASDAQ: WRAP) Stock Analysis: Transforming into AI-Driven Public Safety Platform Arena Signals
[ July 10, 2026 ] Rivian (NASDAQ: RIVN) Stock Analysis: From EV Manufacturer to AI-Powered Mobility Platform Arena Signals
[ July 9, 2026 ] nLIGHT (NASDAQ: LASR) Stock Analysis: $627M Pentagon Award Validates the Next Phase of Growth Arena Signals

Celyad (NASDAQ: CYAD) CEO Christian Homsy shares his vision for universal CAR-T

March 19, 2018 admin Comments Off

Celyad (NASDAQ: CYAD) CEO Christian Homsy shares his vision for universal CAR-T

How to Trade Biotech and Pharmaceutical Stocks

March 11, 2018 admin Comments Off

How to Trade Biotech and Pharmaceutical Stocks Profiting from the FDA approval cycle

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

March 10, 2018 admin Comments Off

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

Picking Biotech Stocks in the Trump Era

February 7, 2018 admin Comments Off

Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301

January 10, 2018 admin Comments Off

PALATINE, Ill., Jan 08, 2018 -Acura Pharmaceuticals, Inc. (OTC QB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from clinical study AP-LTX-301 (Study 301) for its LIMITx(TM) excess oral […]

Acura Pharmaceuticals, Inc (NASDAQ:ACUR) CEO Interview

November 26, 2012 admin Comments Off

Acura Pharmaceuticals, Inc (NASDAQ:ACUR)
Interview with Bob Jones, CEO […]

No Picture

Fluoro Pharma Medical (OTCBB:FPMI) CEO Interview

November 26, 2012 admin Comments Off

Fluoro Pharma Medical (OTCBB:FPMI)
Interview with Thijs Spoor, CEO and Chairman […]

CardioComm Solutions (TSX.V:EKG) CEO Interview

February 9, 2012 admin Comments Off

CardioComm Solutions (TSX.V:EKG) CEO: Etienne Grima […]

CEO Interview

StemCells, Inc (NASDAQ:STEM) CEO Interview

September 23, 2011 admin Comments Off

StemCells, Inc (NASDAQ:STEM)
Interview with Martin McGlynn, Ceo […]

REVA Medical (ASX:RVA) CEO Interview

September 16, 2011 admin Comments Off

REVA Medical (ASX:RVA)
Interview with Bob Stockman, Ceo […]

CEO Interview

IsoRay, Inc. (AMEX: ISR) CEO Interview

October 13, 2010 admin Comments Off

IsoRay, Inc. (AMEX: ISR)
Interview with Dwight Babcock, Chairman and CEO […]

Long-Term Contract in Place for Safety Syringe Platform: Revolutions Medical

September 9, 2010 admin Comments Off

Revolutions Medical Corp (OTC BB: RMCP)
Interview with Ron Wheet, CEO […]

Cardiogenesis Corporation: Positive Results from STAR-Heart Study

September 3, 2010 admin Comments Off

Cardiogenesis Corporation (OTC QB: CGCP)
Interview with Paul J. McCormick, Executive Chairman […]

Carbonium Core (NASDAQ: TOMZ) CEO Details Strategy to Supply Critical Material Powering the AI-Driven Nuclear Renaissance

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) CEO Details Strategy to Supply Critical Material Powering the AI-Driven Nuclear Renaissance
TOMI Environmental (NASDAQ: TOMZ) Announces Definitive Agreement to Merge with Carbonium Core

July 1, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Announces Definitive Agreement to Merge with Carbonium Core
TOMI (NASDAQ: TOMZ) Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending

June 23, 2026 Comments Off on TOMI (NASDAQ: TOMZ) Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

June 10, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets
Myseum.AI (NASDAQ: MYSE) Announces Sponsorship and Panel Participation at Visual 1st 2026 Conference for Global Photo and Video industry

June 10, 2026 Comments Off on Myseum.AI (NASDAQ: MYSE) Announces Sponsorship and Panel Participation at Visual 1st 2026 Conference for Global Photo and Video industry
TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

June 8, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?
Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite

July 1, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite
FIFA World Cup + Biosecurity + Robotics = The $TOMZ Opportunity

June 5, 2026 Comments Off on FIFA World Cup + Biosecurity + Robotics = The $TOMZ Opportunity
Next Super Stock (NASDAQ: TOMZ) We Saw This Before: Axon Went From $1.50 to $800+

June 4, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) We Saw This Before: Axon Went From $1.50 to $800+

Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?
Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite

July 1, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite
Next Super Stock Myseum (NASDAQ: MYSE) $100 Billion Opportunity: $MYSE is What Instagram was Meant to Be!

April 1, 2026 Comments Off on Next Super Stock Myseum (NASDAQ: MYSE) $100 Billion Opportunity: $MYSE is What Instagram was Meant to Be!
Next Super Stock (NASDAQ: CXAI) Driving AI Workplace Transformation – $100+ BILLION Market

December 16, 2025 Comments Off on Next Super Stock (NASDAQ: CXAI) Driving AI Workplace Transformation – $100+ BILLION Market

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.